Studies for physiological functions of human CYP3A enzymes and their clinical applications
Project/Area Number |
15K08067
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Medical pharmacy
|
Research Institution | Chiba University |
Principal Investigator |
Kobayashi Kaoru 千葉大学, 大学院薬学研究院, 准教授 (30255864)
|
Project Period (FY) |
2015-04-01 – 2018-03-31
|
Project Status |
Completed (Fiscal Year 2017)
|
Budget Amount *help |
¥4,940,000 (Direct Cost: ¥3,800,000、Indirect Cost: ¥1,140,000)
Fiscal Year 2017: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2016: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
Fiscal Year 2015: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
Keywords | CYP3A / テストステロン / ノックアウトマウス / 前立腺 / コレステロール / ヒト化動物 |
Outline of Final Research Achievements |
Results of this study showed that remarkable increase in free testosterone in plasma enhanced androgen response in the prostate of Cyp3a-knockout (KO) mice. Increased testosterone levels activated the androgen receptor (AR), resulting in stimulation of cholesterol synthesis in the prostates of Cyp3a-KO mice. In addition, KO of Cyp3a genes enhanced the synthesis of cholesterol in the liver via activation of SREBP-2 by reduction of 25-hydroxycholesterol. These findings suggest that CYP3A is a regulator for androgen response in the prostate and for synthesis of cholesterol in the liver.
|
Report
(4 results)
Research Products
(6 results)